Regulated Clinical Laboratory Testing Services for Clinical Trials


Caprion is accredited by the College of American Pathologists (CAP) and has a certificate of accreditation from the Clinical Laboratory Improvement Amendments (CLIA).

CAP Accreditation (CAP Number: 9422124)
CLIA Certification (CLIA Number 99D2126355)

Our testing services are available for clients who require testing services to support their clinical trials development.
Our testing services at our Montreal, Quebec, Canada laboratory include the following, but we are always expanding our CAP/CLIA testing portfolio:

  • TBNK (Flow Cytometry)
  • CD34+ (Flow Cytometry)
  • Rituximab (ELISA)
  • Leukemia/lymphoma/myelodysplastic syndrome (MDS) immunophenotyping (Flow Cytometry)
  • SARS-CoV-2 viral nucleic acid amplification by rt-PCR (Molecular Microbiology)

Our quality management system (QMS) drives harmonization of specific testing services and is implemented at all levels of the organization.

Contact us for more information